Document is current
Any future updates will be listed below
-
Authors
Idalsoaga, Francisco https://orcid.org/0000-0001-5607-0698
Díaz, Luis Antonio https://orcid.org/0000-0002-8540-4930
Barrera, Francisco https://orcid.org/0000-0001-5334-1528
Gadano, Adrian https://orcid.org/0000-0002-3590-2472
Oliveira, Claudia P. https://orcid.org/0000-0002-2848-417X
Arab, Juan Pablo https://orcid.org/0000-0002-8561-396X
Arrese, Marco https://orcid.org/0000-0002-0499-4191
- License Information
-
More Information
Article History
Accepted: 22 May 2026
First Online: 15 June 2026
Competing interests
: M.A. consults for Inventiva and AstraZeneca and has served as a speaker for Siemens. C.P.O. consults for NovoNordisk, Boehringer Ingelheim, Inventiva, AstraZeneca, Echosens, Samsung and Siemens and has served as a speaker for NovoNordisk and Boehringer Ingelheim. The other authors declare no competing interests.
